Idorsia Ltd

Status: Publicly traded

Direct answer

Idorsia Ltd is publicly traded on SIX under the ticker IDIA.SW.

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. It offers QUVIVIQ (daridorexant) for the treatment of...

Can you invest in Idorsia Ltd?

Yes. Idorsia Ltd is publicly traded on SIX under the ticker IDIA.SW.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Idorsia Ltd

Detailed equity research is provided by MarketSnap.